TNF-α in tuberculosis: A cytokine with a split personality

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 1, 2009, Pages 53-62

  Mootoo, Amanda ^a   Stylianou, Elena ^a   Arias, Mauricio A ^a   Reljic, Rajko ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Granuloma; Macrophage; Mycobacterium; TNF ; Tuberculosis

Indexed keywords

ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; CELL MATURATION; CELL MOTION; CYTOKINE PRODUCTION; DENDRITIC CELL; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POSTPRIMARY TUBERCULOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TISSUE INJURY; TUBERCULOSIS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; DENDRITIC CELLS; GRANULOMA; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; TH1 CELLS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349501640     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809787582543     Document Type: Review

References (108)

1. Granger, G.A.; Shacks, S.J.; Williams, T.W.; Kolb, W.P. Lymphocyte in Vitro cytotoxicity - Specific release of Lymphotoxin-like materials from Tuberculin-sensitive lymphoid cells. Nature, 1969, 221, 1155-1157.
2. Carswell, E.A.; Old, L.J.; Kassel, R.L.; Green, S.; Fiore, N.; Williamson, B. Endotoxin-induced serum factor that causes necrosis of tumours. Proc. Natl. Acad. Sci. USA, 1975, 72, 3666-3670.
3. Pennica, D.; Nedwin, G.E.; Hayflick, J.S.; Seeburg, P.H.; Derynck, R.; Palladino, M.A.; Kohr, W.J.; Aggarwal, B.B.; Goeddel, D.V. Human-tumour necrosis factor - Precursor structure, expression and homology to lymphotoxin. Nature, 1984, 312, 724-729.
4. Tang, P.; Hung, M.C.; Klostergaard, J. Human pro-tumour necrosis factor is a homotrimer. Biochemistry, 1996, 35, 8216-8225.
5. Black, R.A.; Rauch, C.T.; Kozlosky, C.J.; Peschon, J.J.; Slack, J.L.; Wolfson, M.F.; Castner, B.J.; Stocking, K.L.; Reddy, P.; Srinivasan, S.; Nelson, N.; Boiani, N.; Schooley, K.A.; Gerhart, M.; Davis, R.; Fitzner, J.N.; Johnson, R.S.; Paxton, R.J.; March, C.J.; Cerretti, D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, 1997, 385, 729-733.
6. Ehlers, S. Role of tumour necrosis factor (TNF) in host defence against tuberculosis: Implications for immunotherapies targeting TNF. Ann. Rheum. Dis., 2003, 62, 37-42.
7. Sprang, S.R. The Divergent Receptors for Tnf. Trends Biochem. Sci., 1990, 15, 366-368.
8. Wajant, H.; Pfizenmaier, K.; Scheurich, P. Tumour necrosis factor signaling. Cell Death Differ., 2003, 10, 45-65.
9. Kriegler, M.; Perez, C.; Defay, K.; Albert, I.; Lu, S.D. A novel form of Tnf/Cachectin is a cell-surface cyto-toxic transmembrane protein - Ramifications for the complex physiology of Tnf. Cell, 1988, 53, 45-53.
10. Chen, G.Q.; Goeddel, D.V. TNF-R1 signaling: A beautiful pathway. Science, 2002, 296, 1634-1635.
11. Houben, E.N.G.; Nguyen, L.; Pieters, J. Interaction of pathogenic mycobacteria with the host immune system. Curr. Opin. Microbiol., 2006, 9, 76-85.
12. Vankayalapati, R.; Wizel, B.; Weis, S.E.; Klucar, P.; Shams, H.; Samten, B.; Barnes, P.F. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis - Induced cytokine production in patients with tuberculosis. Clin. Infect. Dis., 2003, 36, 24-28.
13. Chan, J.; Xing, Y.; Magliozzo, R.S.; Bloom, B.R. Killing of virulent Mycobacterium-Tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med., 1992, 175, 1111-1122.
14. Thoma-Uszynski, S.; Stenger, S.; Takeuchi, O.; Ochoa, M.T.; Engele, M.; Sieling, P.A.; Barnes, P. F.; Rollinghoff, M.; Bolcskei, P.L.; Wagner, M.; Akira, S.; Norgard, M.V.; Belisle, J.T.; Godowski, P.J.; Bloom, B.R.; Modlin, R.L. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science, 2001, 291, 1544-1547.
15. Hirsch, C.S.; Yoneda, T.; Averill, L.; Ellner, J.J.; Toossi, Z. Enhancement of intracellular growth of Mycobacterium-Tuberculosis in human monocytes by transforming growth-factor-Beta-1. J. Infect. Dis., 1994, 170, 1229-1237.
16. Toossi, Z. The inflammatory response in Mycobacterium tuberculosis infection. Arch. Immunol. Ther. Exp. (Warsz), 2000, 48, 513-519.
17. Valone, S.E.; Rich, E.A.; Wallis, R.S.; Ellner, J.J. Expression of tumour necrosis factor invitro by human mononuclear phagocytes stimulated with whole Mycobacterium-Bovis Bcg and mycobacterial antigens. Infect. Immun., 1988, 56, 3313-3315.
18. Jacobs, M.; Togbe, D.; Fremond, C.; Samarina, A.; Allie, N.; Botha, T.; Carlos, D.; Parida, S.K.; Grivennikov, S.; Nedospasov, S.; Monteiro, A.; Le Bert, M.; Quesniaux, V.; Ryffel, B. Tumour necrosis factor is critical to control tuberculosis infection. Microbes Infect., 2007, 9, 623-628.
19. Lin, P.L.; Plessner, H.L.; Voitenok, N.N.; Flynn, J.L. Tumour necrosis factor and tuberculosis. J. Investig. Dermatol. Symp. Proc., 2007, 12, 22-25.
20. Stenger, S. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann. Rheum. Dis., 2005, 64 Suppl 4, iv24-iv28.
21. Kaufmann, S.H.E. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann.Rheum. Dis., 2002, 61, 54-58.
22. Jacobs, M.; Brown, N.; Allie, N.; Ryffel, B. Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin. Immunol., 2000, 94, 192-199.
23. Ehlers, S.; Benini, J.; Kutsch, S.; Endres, R.; Rietschel, E.T.; Pfeffer, K. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumour necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect. Immun., 1999, 67, 3571-3579.
24. Fenhalls, G.; Wong, A.; Bezuidenhout, J.; van Helden, P.; Bardin, P.; Lukey, P.T. In situ production of gamma interferon, interleukin-4, and tumour necrosis factor alpha mRNA in human lung tuberculous granulomas. Infect. Immun., 2000, 68, 2827-2836.
25. Aung, H.; Toossi, Z.; Wisnieski, J.J.; Wallis, R.S.; Culp, L.A.; Phillips, N.B.; Phillips, M.; Averill, L. E.; Daniel, T.M.; Ellner, J.J. Induction of monocyte expression of tumour necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. J. Clin. Invest., 1996, 98, 1261-1268.
26. Barnes, P.F.; Chatterjee, D.; Abrams, J.S.; Lu, S.H.; Wang, E.; Yamamura, M.; Brennan, P. J.; Modlin, R.L. Cytokine production induced by Mycobacterium-Tuberculosis lipoarabinomannan - relationship to chemical-structure. J. Immunol., 1992, 149, 541-547.
27. Abel, B.; Thieblemon, N.; Quesniaux, V.J.F.; Brown, N.; Mpagi, J.; Miyake, K.; Bihl, F.; Ryffel, B. Toll-like receptor 4 expression is required to control chronic Mycobacterium Tuberculosis infection in mice. J. Immunol., 2002, 169, 3155-3162.
28. Drennan, M.B.; Nicolle, D.; Quesniaux, V.J.F.; Jacobs, M.; Allie, N.; Mpagi, J.; Fremond, C.; Wagner, H.; Kirschning, C.; Ryffel, B. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am. J. Pathol., 2004, 164, 49-57.
29. Reiling, N.; Holscher, C.; Fehrenbach, A.; Kroger, S.; Kirschning, C.J.; Goyert, S.; Ehlers, S. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol., 2002, 169, 3480-3484.
30. Scanga, C.A.; Bafica, A.; Feng, C.G.; Cheever, A.W.; Hieny, S.; Sher, A. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect. Immun., 2004, 72, 2400-2404.
31. Underhill, D.M.; Ozinsky, A.; Smith, K.D.; Aderem, A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA, 1999, 96, 14459-14463.
32. Toossi, Z. Cytokine circuits in tuberculosis. Infect. Agents Dis., 1996, 5, 98-107.
33. Fenton, M.J.; Vermeulen, M.W.; Kim, S.; Burdick, M.; Strieter, R.M.; Kornfeld, H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun., 1997, 65, 5149-5156.
34. Kemp, K.; Hviid, L.; Kharazmi, A.; Kemp, M. Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major. Scand. J. Immunol., 1997, 46, 495-499.
35. Torres, M.; Herrera, T.; Villareal, H.; Rich, E.A.; Sada, E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect. Immun., 1998, 66, 176-180.
36. Toossi, Z.; Gogate, P.; Shiratsuchi, H.; Young, T.; Ellner, J.J. Enhanced production of Tgf-Beta by blood monocytes from Patients with active tuberculosis and presence of Tgf-Beta in Tuberculous granulomatous lung lesions. J. Immunol., 1995, 154, 465-473.
37. Tailleux, L.; Pham-Thi, N.; Bergeron-Lafaurie, A.; Herrmann, J.L.; Charles, P.; Schwartz, O.; Scheinmann, P.; Lagrange, P.H.; de Blic, J.; Tazi, A.; Gicquel, B.; Neyrolles, O. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. PLoS Med., 2005, 2, 1269-1279.
38. Geijtenbeek, T.B.H.; van Vliet, S.J.; Koppel, E.A.; Sanchez-Hernandez, M.; Vandenbroucke-Grauls, C.M.J.E.; Appelmelk, B.; van Kooyk, Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med., 2003, 197, 7-17.
39. Gringhuis, S.I.; Den Dunnen, J.; Litjens, M.; Hof, B.V.; van Kooyk, Y.; Geijtenbeek, T.B.H. C-type lectin DC-SIGN modulates toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappa B. Immunity, 2007, 26, 605-616.
40. Fratazzi, C.; Arbeit, R.D.; Carini, C.; Remold, H.G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol., 1997, 158, 4320-4327.
41. Fratazzi, C.; Arbeit, R.D.; Carini, C.; Balcewicz-Sablinska, M. K.; Keane, J.; Kornfeld, H.; Remold, H. G. Macrophage apoptosis in mycobacterial infections. J. Leukoc. Biol., 1999, 66, 763-764.
42. Schaible, U.E.; Winau, F.; Sieling, P.A.; Fischer, K.; Collins, H.L.; Hagens, K.; Modlin, R. L.; Brinkmann, V.; Kaufmann, S.H.E. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med., 2003, 9, 1039-1046.
43. Rojas, M.; Olivier, M.; Gros, P.; Barrera, L.F.; Garcia, L.F. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J. Immunol., 1999, 162, 6122-6131.
44. Gil, D.P.; Leon, L.G.; Correa, L.I.; Maya, J.R.; Paris, S.C.; Garcia, L.F.; Rojas, M. Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects. J. Infect. Dis., 2004, 189, 2120-2128.
45. Molloy, A.; Laochumroonvorapong, P.; Kaplan, G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus-calmette-guerin. J. Exp. Med., 1994, 180, 1499-1509.
46. Oddo, M.; Renno, T.; Attinger, A.; Bakker, T.; MacDonald, H.R.; Meylan, P.R.A. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol., 1998, 160, 5448-5454.
47. Banchereau, J.; Briere, F.; Caux, C.; Davoust, J.; Lebecque, S.; Liu, Y.T.; Pulendran, B.; Palucka, K. Immunobiology of dendritic cells. Annu. Rev. Immunol., 2000, 18, 767.
48. Holt, P.G. Antigen presentation in the lung. Am. J. Respir. Crit. Care Med., 2000, 162, S151-S156.
49. Stenger, S.; Hanson, D.A.; Teitelbaum, R.; Dewan, P.; Niazi, K.R.; Froelich, C.J.; Ganz, T.; Thoma-Uszynski, S.; Melian, A.; Bogdan, C.; Porcelli, S.A.; Bloom, B.R.; Krensky, A.M.; Modlin, R.L. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science, 1998, 282, 121-125.
50. Cella, M.; Sallusto, F.; Lanzavecchia, A. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol., 1997, 9, 10-16.
51. Santiagoschwarz, F.; Belilos, E.; Diamond, B.; Carsons, S.E. Tnf in combination with Gm-Csf enhances the differentiation of neonatal cord blood stem-cells into dendritic cells and macrophages. J. Leukoc. Biol., 1992, 52, 274-281.
52. Santiagoschwarz, F.; Divaris, N.; Kay, C.; Carsons, S.E. Mechanisms of tumour-necrosis-factor granulocyte-macrophage colony-stimulating factor - induced dendritic cell-development. Blood, 1993, 82, 3019-3028.
53. Iwamoto, S.; Iwai, S.; Tsujiyama, K.; Kurahashi, C.; Takeshita, K.; Naoe, M.; Masunaga, A.; Ogawa, Y.; Oguchi, K.; Miyazaki, A. TNF-alpha drives human CD14(+) monocytes to differentiate into CD70(+) dendritic cells evoking Th1 and Th17 responses. J. Immunol., 2007, 179, 1449-1457.
54. Buettner, M.; Meinken, H.; Bastian, M.; Bhat, R.; Stossel, E.; Faller, G.; Cianciolo, G.; Ficker, J.; Wagner, M.; Rollinghoff, M.; Stenger, S. Inverse correlation of maturity and antibacterial activity in human dendritic cells. J. Immunol., 2005, 174, 4203-4209.
55. Cheadle, E.J.; Selby, P.J.; Jackson, A.M. Mycobacterium bovis bacillus Calmette-Guerin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism. Immunology, 2003, 108, 79-88.
56. Hanekom, W.A.; Mendillo, M.; Manca, C.; Haslett, P.A.J.; Siddiqui, M.R.; Barry, C.; Kaplan, G. Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J. Infect. Dis., 2003, 188, 257-266.
57. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A.; Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol., 2004, 25, 677-686.
58. Algood, H.M.S.; Chan, J.; Flynn, J.L. Chemokines and tuberculosis. Cytokine Growth Factor Rev., 2003, 14, 467-477.
59. Peters, W.; Ernst, J.D. Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. Microbes Infect., 2003, 5, 151-158.
60. Lin, Y.G.; Gong, J.H.; Zhang, M.; Xue, W.F.; Barnes, P. F. Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect. Immun., 1998, 66, 2319-2322.
61. Miotto, D.; Christodoulopoulos, P.; Olivenstein, R.; Taha, R.; Cameron, L.; Tsicopoulos, A.; Tonnel, A.B.; Fahy, O.; Lafitte, J.J.; Luster, A. D.; Wallaert, B.; Mapp, C.E.; Hamid, Q. Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in T(H)1-and T(H)2-mediated lung diseases. J. Allergy Clin. Immunol., 2001, 107, 664-670.
62. Sadek, M.I.; Sada, E.; Toossi, Z.; Schwander, S.K.; Rich, E.A. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am. J. Respir. Cell Mol. Biol., 1998, 19, 513-521.
63. Saukkonen, J.J.; Bazydlo, B.; Thomas, M.; Strieter, R.M.; Keane, J.; Kornfeld, H. beta-Cchemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect. Immun., 2002, 70, 1684-1693.
64. Sauty, A.; Dziejman, M.; Taha, R.A.; Iarossi, A.S.; Neote, K.; Garcia-Zepeda, E.A.; Hamid, Q.; Luster, A.D. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol., 1999, 162, 3549-3558.
65. Wickremasinghe, M.I.; Thomas, L.H.; Friedland, J.S. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: Essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. J. Immunol., 1999, 163, 3936-3947.
66. Gerszten, R.E.; Garcia-Zepeda, E.A.; Lim, Y.C.; Yoshida, M.; Ding, H.A.; Gimbrone, M.A.; Luster, A.D.; Luscinskas, F.W.; Rosenzweig, A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature, 1999, 398, 718-723.
67. Randolph, G.J.; Beaulieu, S.; Lebecque, S.; Steinman, R.M.; Muller, W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science, 1998, 282, 480-483.
68. McWilliam, A.S.; Napoli, S.; Marsh, A.M.; Pemper, F.L.; Nelson, D.J.; Pimm, C.L.; Stumbles, P.A.; Wells, T.N.C.; Holt, P.G. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med., 1996, 184, 2429-2432.
69. Sertl, K.; Takemura, T.; Tschachler, E.; Ferrans, V.J.; Kaliner, M.A.; Shevach, E.M. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med., 1986, 163, 436-451.
70. Sallusto, F.; Schaerli, P.; Loetscher, P.; Schaniel, C.; Lenig, D.; Mackay, C.R.; Qin, S.X.; Lanzavecchia, A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol., 1998, 28, 2760-2769.
71. Flynn, J.L.; Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol., 2001, 19, 93-129.
72. Sozzani, S.; Allavena, P.; D'Amico, G.; Luini, W.; Bianchi, G.; Kataura, M.; Imai, T.; Yoshie, O.; Bonecchi, R.; Mantovani, A. Cutting edge: Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties. J. Immunol., 1998, 161, 1083-1086.
73. Bhatt, K.; Hickman, S.P.; Salgame, P. Cutting edge: A new approach to modeling early lung immunity in murine tuberculosis. J. Immunol., 2004, 172, 2748-2751.
74. Cyster, J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med., 1999, 189, 447-450.
75. Marino, S.; Pawar, S.; Fuller, C.L.; Reinhart, T.A.; Flynn, J.L.; Kirschner, D.E. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J. Immunol., 2004, 173, 494-506.
76. Kurashima, K.; Mukaida, N.; Fujimura, M.; Yasui, M.; Nakazumi, Y.; Matsuda, T.; Matsushima, K. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am. J. Respir. Crit. Care Med., 1997, 155, 1474-1477.
77. Fuller, C.L.; Flynn, J.A.L.; Reinhart, T.A. In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect. Immun., 2003, 71, 7023-7034.
78. Roach, D.R.; Bean, A.G.D.; Demangel, C.; France, M.P.; Briscoe, H.; Britton, W.J. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol., 2002, 168, 4620-4627.
79. Algood, H.M.S.; Lin, P.L.; Yankura, D.; Jones, A.; Chan, J.; Flynn, J.L. Influences chemokine expression of macrophages in vitro and that of CD11b(+) cells in vivo during mycobacterium tuberculosis infection. J. Immunol., 2004, 172, 6846-6857.
80. Gardam, M.A.; Keystone, E.C.; Menzies, R.; Manners, S.; Skamene, E.; Long, R.; Vinh, D.C. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis., 2003, 3, 148-155.
81. Saunders, B.M.; Tran, S.; Ruuls, S.; Sedgwick, J.D.; Briscoe, H.; Britton, W.J. Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J. Immunol., 2005, 174, 4852-4859.
82. Newton, S.M.; Mackie, S.L.; Martineau, A.R.; Wilkinson, K.A.; Kampmann, B.; Fisher, C.; Dutta, S.; Levin, M.; Wilkinson, R.J.; Pasvol, G. Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin. Vaccine Immunol., 2008, 15, 506-512.
83. Mantovani, A. The chemokine system: redundancy for robust outputs. Immunol. Today, 1999, 20, 254-257.
84. Di Liberto, D.; Locati, M.; Caccamo, N.; Vecchi, A.; Meraviglia, S.; Salerno, A.; Sireci, G.; Nebuloni, M.; Caceres, N.; Cardona, P.J.; Dieli, F.; Mantovani, A. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J. Exp. Med., 2008, 205, 2075-84.
85. Byrd, T.F. Tumour necrosis factor alpha (TNF alpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes - Iron-mediated growth suppression is correlated with decreased release of TNF alpha from iron-treated infected monocytes. J. Clin. Invest., 1997, 99, 2518-2529.
86. Silver, R.F.; Li, Q.; Ellner, J.J. Expression of virulence of Mycobacterium tuberculosis within human monocytes: Virulence correlates with intracellular growth and induction of tumour necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect.Immun., 1998, 66, 1190-1199.
87. Filley, E.A.; Rook, G.A.W. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumour-necrosis-factor. Infect. Immun., 1991, 59, 2567-2572.
88. Filley, E.A.; Bull, H.A.; Dowd, P.M.; Rook, G.A.W. The Effect of Mycobacterium-Tuberculosis on the Susceptibility of Human-Cells to the Stimulatory and Toxic Effects of Tumour-Necrosis-Factor. Immunology, 1992, 77, 505-509.
89. Rook, G.A.W.; HernandezPando, R. The pathogenesis of tuberculosis. Annu. Rev. Microbiol., 1996, 50, 259-284.
90. Brenner, D.A.; Ohara, M.; Angel, P.; Chojkier, M.; Karin, M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-Alpha. Nature, 1989, 337, 661-663.
91. Solisherruzo, J.A.; Brenner, D.A.; Chojkier, M. Tumour necrosis factor-alpha inhibits collagen gene-transcription and collagen-synthesis in cultured human-fibroblasts. J. Biol. Chem., 1988, 263, 5841-5845.
92. Florido, M.; Appelberg, R. Characterization of the deregulated immune activation occurring at late stages of mycobacterial infection in TNF-deficient mice. J. Immunol., 2007, 179, 7702-7708.
93. Chakravarty, S.D.; Zhu, G.F.; Tsai, M.C.; Mohan, V.P.; Marino, S.; Kirschner, D.E.; Huang, L.Q.; Flynn, J.; Chan, J. Tumour necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect. Immun., 2008, 76, 916-926.
94. Zganiacz, A.; Santosuosso, M.; Wang, J.; Yang, T.; Chen, L.H.; Anzulovic, M.; Alexander, S.; Gicquel, B.; Wan, Y.H.; Bramson, J.; Inman, M.; Xing, Z. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest., 2004, 113, 401-413.
95. Scallon, B.; Cai, A.; Solowski, N.; Rosenberg, A.; Song, X.Y.; Shealy, D.; Wagner, C. Binding and functional comparisons of two types of tumour necrosis factor antagonists. J. Pharmacol. Exp. Ther., 2002, 301, 418-426.
96. Wallis, R.S.; Broder, M.S.; Wong, J.Y.; Hanson, M.E.; Beenhouwer, D.O. Granulomatous infectious diseases associated with tumour necrosis factor antagonists. Clin. Infect. Dis., 2004, 38, 1261-1265.
97. Steed, P.M.; Tansey, M.G.; Zalevsky, J.; Zhukovsky, E.A.; Desjarlais, J.R.; Szymkowski, D. E.; Abbott, C.; Carmichael, D.; Chan, C.; Cherry, L.; Cheung, P.; Chirino, A.J.; Chung, H.H.; Doberstein, S.K.; Eivazi, A.; Filikov, A.V.; Gao, S.X.; Hubert, R.S.; Hwang, M.; Hyun, L.; Kashi, S.; Kim, A.; Kim, E.; Kung, J.; Martinez, S.P.; Muchhal, U.S.; Nguyen, D.H.T.; O'Brien, C.; O'Keefe, D.; Singer, K.; Vafa, O.; Vielmetter, J.; Yoder, S.C.; Dahiyat, B.I. Inactivation of TNF signaling by rationally designed dominant-negative TNF variants. Science, 2003, 301, 1895-1898.
98. Zalevsky, J.; Secher, T.; Ezhevsky, S. A.; Janot, L.; Steed, P.M.; O'Brien, C.; Eivazi, A.; Kung, J.; Nguyen, D.H.T.; Doberstein, S.K.; Erard, F.; Ryffel, B.; Szymkowski, D.E. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J. Immunol., 2007, 179, 1872-1883.
99. Olleros, M.L.; Vesin, D.; Janssen, J.P.; Ryffel, B.; Szymkowski, D.E.; Garcia, I. Blocking soluble TNF with dominant-negative (DN)-TNF molecules protects from Mycobacterium bovis BCG and endotoxin-induced hepatitis but does not suppress host immune responses against M. tuberculosis and M-bovis BCG infections. Eur. J. Clin. Invest., 2008, 38, 56-57.
100. Shibata, H.; Yoshioka, Y.; Ohkawa, A.; Minowa, K.; Mukai, Y.; Abe, Y.; Taniai, M.; Nomura, T.; Kayamuro, H.; Nabeshi, H.; Sugita, T.; Imai, S.; Nagano, K.; Yoshikawa, T.; Fujita, T.; Nakagawa, S.; Yamamoto, A.; Ohta, T.; Hayakawa, T.; Mayumi, T.; Vandenabeele, P.; Aggarwal, B.B.; Nakamura, T.; Yamagata, Y.; Tsunoda, S.; Kamada, H.; Tsutsumi, Y. Creation and x-ray structure analysis of the tumour necrosis factor receptor-1-selective mutant of a tumour necrosis factor-alpha antagonist. J. Biol. Chem., 2008, 283, 998-1007.
101. He, M.M.; Smith, A.S.; Oslob, J.D.; Flanagan, W.M.; Braisted, A.C.; Whitty, A.; Cancilla, M.T.; Wang, J.; Lugovskoy, A.A.; Yoburn, J.C.; Fung, A.D.; Farrington, G.; Eldredge, J.K.; Day, E.S.; Cruz, L.A.; Cachero, T.G.; Miller, S.K.; Friedman, J.E.; Choong, I.C.; Cunningham, B.C. Small-molecule inhibition of TNF-alpha. Science, 2005, 310, 1022-1025.
102. Chan, F.K.M.; Chun, H.J.; Zheng, L.X.; Siegel, R.M.; Bui, K.L.; Lenardo, M.J. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science, 2000, 288, 2351-2354.
103. Deng, G.M.; Zheng, L.X.; Chan, F.K.M.; Lenardo, M. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumour necrosis factor receptors. Nat. Med., 2005, 11, 1066-1072.
104. Flynn, J.L.; Goldstein, M.M.; Chan, J.; Triebold, K.J.; Pfeffer, K.; Lowenstein, C.J.; Schreiber, R.; Mak, T.W.; Bloom, B.R. Tumour-Necrosis-Factor-Alpha Is Required in the Protective Immune-Response Against Mycobacterium-Tuberculosis in Mice. Immunity, 1995, 2, 561-572.
105. Algood, H.M.S.; Flynn, J.L. CCR5-Deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol., 2004, 173, 3287-3296.
106. Kindler, V.; Sappino, A. P.; Grau, G.E.; Piguet, P.F.; Vassalli, P. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during Bcg infection. Cell, 1989, 56, 731-740.
107. Wallis, R.S.; Kyambadde, P.; Johnson, J.L.; Horter, L.; Kittle, R.; Pohle, M.; Ducar, C.; Millard, M.; Mayanja-Kizza, H.; Whalen, C.; Okwerac, A. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS, 2004, 18, 257-264.
108. Mayanja-Kizza, H.; Jones-Lopez, E.; Okwera, A.; Wallis, R.S.; Ellner, J.J.; Mugerwa, R. D.; Whalen, C.C.; Uganda-Case Western Res Collaborat Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: A phase 2 clinical trial in Uganda. J. Infect. Dis., 2005, 191, 856-865.